EZH2 and Miyoshi myopathy: While the treatment of bortezomib reduced M-proteins compared to the vehicle control in wild-type mice (Fig. 8e), the treatment was much more effective in the knockout mice with improved survival (Fig. 8e and f), indicating the functional role of adipocyte EZH2 in MM cell response to chemotherapy.